Mismatch repair deficiency, a future biomarker to guide adjuvant chemotherapy in localized small bowel adenocarcinoma?
Digestive and Liver Disease · 2023
DOI: 10.1016/j.dld.2023.06.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2023. Verfasst von Anthony Turpin. Beteiligte Einrichtung: University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 - UMR-S 1277 - Canther - Cancer Heterogeneity, Plasticity and Resist…. Hauptthemen laut MEDLINE: Adenocarcinoma, Colorectal Neoplasms. Die Arbeit nennt 11 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 - UMR-S 1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France; Medical Oncology Department, CHU Lil…
Zitieren
APA
Turpin, A. (2023). Mismatch repair deficiency, a future biomarker to guide adjuvant chemotherapy in localized small bowel adenocarcinoma?. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.06.019
Vancouver
Turpin A. Mismatch repair deficiency, a future biomarker to guide adjuvant chemotherapy in localized small bowel adenocarcinoma?. Digestive and Liver Disease. 2023. doi:10.1016/j.dld.2023.06.019
BibTeX
@article{Turpin2023,
author = {Turpin, Anthony},
title = {Mismatch repair deficiency, a future biomarker to guide adjuvant chemotherapy in localized small bowel adenocarcinoma?},
journal = {Digestive and Liver Disease},
year = {2023},
doi = {10.1016/j.dld.2023.06.019}
}
EUVIMED